1180833

Novartis Pharma AG — FEI 3002807772

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 30, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Basel (Switzerland)